share_log

Guggenheim Reiterates Buy on ADC Therapeutics

Moomoo 24/7 ·  Apr 5 09:55

Guggenheim analyst Michael Schmidt reiterates ADC Therapeutics (NYSE:ADCT) with a Buy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment